Impact of Palliative Care Involvement on End-of-Life Care Patterns Among Adolescents and Young Adults With Cancer: A Population-Based Cohort Study.


Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333

Informations de publication

Date de publication:
01 08 2021
Historique:
pubmed: 8 6 2021
medline: 22 12 2021
entrez: 7 6 2021
Statut: ppublish

Résumé

Evidence suggests that adolescents and young adults (AYAs) with cancer (defined as age 15-39 years) receive high-intensity (HI) medical care at the end-of-life (EOL). Previous population-level studies are limited and lack information on the impact of palliative care (PC) provision. We evaluated prevalence and predictors of HI-EOL care in AYAs with cancer in Ontario, Canada. A secondary aim was to evaluate the impact of PC physicians on the intensity of EOL care in AYAs. A retrospective decedent cohort of AYAs with cancer who died between 2000 and 2017 in Ontario, Canada, was assembled using a provincial registry and linked to population-based health care data. On the basis of previous studies, the primary composite measure HI-EOL care included any of the following: intravenous chemotherapy < 14 days from death, more than one emergency department visit, and more than one hospitalization or intensive care unit admission < 30 days from death. Secondary measures included the most invasive (MI) EOL care (eg, mechanical ventilation < 14 days from death) and PC physician involvement. We determined predictors of outcomes using appropriate regression models. Of 7,122 AYAs, 43.8% experienced HI-EOL care. PC physician involvement (odds ratio [OR], 0.57; 95% CI, 0.51 to 0.63) and older age at death (OR, 0.60; 95% CI, 0.48 to 0.74) were associated with a lower risk of HI-EOL care. AYAs with hematologic malignancies were at highest risk for HI and MI-EOL care. PC physician involvement substantially reduced the odds of mechanical ventilation at EOL (OR, 0.36; 95% CI, 0.30 to 0.43). A large proportion of AYAs with cancer experience HI-EOL care. Our study provides strong evidence that PC physician involvement can help mitigate the risk of HI and MI-EOL care in AYAs with cancer.

Identifiants

pubmed: 34097441
doi: 10.1200/JCO.20.03698
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2506-2515

Auteurs

Alisha Kassam (A)

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
Department of Pediatrics and Division of Palliative Care, Southlake Regional Health Centre, Newmarket, ON, Canada.
Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Abha Gupta (A)

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Adam Rapoport (A)

Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Paediatric Advanced Care Team, The Hospital for Sick Children, Toronto, ON, Canada.
Emily's House Children's Hospice, Toronto, ON, Canada.

Amirrtha Srikanthan (A)

Department of Medical Oncology, The Ottawa Hospital, Ottawa, ON, Canada.
Faculty of Medicine, University of Ottawa, Toronto, ON, Canada.

Rinku Sutradhar (R)

Cancer Research Program, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.

Jin Luo (J)

Cancer Research Program, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.

Kimberley Widger (K)

Paediatric Advanced Care Team, The Hospital for Sick Children, Toronto, ON, Canada.
Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada.

Joanne Wolfe (J)

Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA.
Department of Pediatrics, Boston Children's Hospital, Boston, MA.

Craig Earle (C)

Cancer Research Program, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.

Sumit Gupta (S)

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Cancer Research Program, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.
Institute for Health Policy, Evaluation and Management, University of Toronto, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH